Wang Na, Wu Si, Huang Lanxiang, Hu Yue, He Xin, He Jourong, Hu Ben, Xu Yaqi, Rong Yuan, Yuan Chunhui, Zeng Xiantao, Wang Fubing
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Center for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
J Biomed Sci. 2025 Feb 19;32(1):23. doi: 10.1186/s12929-025-01117-x.
Recent advancements have revealed the presence of a microbiome within tumor tissues, underscoring the crucial role of the tumor microbiome in the tumor ecosystem. This review delves into the characteristics of the intratumoral microbiome, underscoring its dual role in modulating immune responses and its potential to both suppress and promote tumor growth. We examine state-of-the-art techniques for detecting and analyzing intratumoral bacteria, with a particular focus on their interactions with the immune system and the resulting implications for cancer prognosis and treatment. By elucidating the intricate crosstalk between the intratumoral microbiome and the host immune system, we aim to uncover novel therapeutic strategies that enhance the efficacy of cancer treatments. Additionally, this review addresses the existing challenges and future prospects within this burgeoning field, advocating for the integration of microbiome research into comprehensive cancer therapy frameworks.
最近的进展揭示了肿瘤组织中微生物群的存在,突显了肿瘤微生物群在肿瘤生态系统中的关键作用。本综述深入探讨了肿瘤内微生物群的特征,强调了其在调节免疫反应中的双重作用以及抑制和促进肿瘤生长的潜力。我们研究了检测和分析肿瘤内细菌的先进技术,特别关注它们与免疫系统的相互作用以及对癌症预后和治疗的影响。通过阐明肿瘤内微生物群与宿主免疫系统之间复杂的相互作用,我们旨在发现提高癌症治疗效果的新治疗策略。此外,本综述还探讨了这一新兴领域现有的挑战和未来前景,主张将微生物群研究纳入全面的癌症治疗框架。